More Potential | Boehringer Ingelheim

MORE POTENTIAL for Communities & our People

MORE POTENTIAL builds on our culture to activate our employees and partners for impact. It integrates work that enables our people to realize their potential through our culture and leadership approach. It also aims to improve the health of people and animals in underserved communities through social engagement.

Topics of interest

Three illustrated women working and science before yellow background, animated

Passion for science

Discover how our women excelling in STEM careers can improve health equity and create sustainable healthcare solutions.

Promoting collaborations for social impact

Two social entrepreneurs connecting at Making More Health Together

More Potential

Promoting collaborations for social impact

Read how Making More Health Together is connecting changemakers to drive collaborations for more social impact.

Imagine: The impact of volunteering activities on elderly well-being

Image of the B-Effect program in Seoul, Korea

More Potential

Imagine: The impact of volunteering activities on elderly well-being

How our employee volunteers enhance elderly well-being and inter-generational connections across Australia, South Korea, Southeast Asia, and New Zealand.

Women at the workplace: Inspiring inclusion for positive change

More Potential

Women at the workplace: Inspiring inclusion for positive change

Leadership views on how to enhance women’s progress at work

Bekenntnis zur Achtung der Menschenrechte

Our commitment to respect Human Rights

A central element of our corporate responsibility.

Download

Joint Modern Slavery & Child Labor Statement 2023

This statement describes our measures against forced labor and child labor.

Download

Report LkSG 2023 C.H. Boehringer Sohn AG & Co. KG

Starting from the fiscal year 2023, C.H. Boehringer Sohn AG & Co. KG reports annually to the German Federal Office for Economic Affairs and Export Control. It describes our human rights due diligence measures in accordance with the German Supply Chain Due Diligence Act (LkSG) in German Language.

Download

Report LkSG Boehringer Ingelheim Pharma GmbH & Co. KG

Starting from the fiscal year 2023, Boehringer Ingelheim Pharma GmbH & Co. KG reports annually to the German Federal Office for Economic Affairs and Export Control. It describes our human rights due diligence measures in accordance with the German Supply Chain Due Diligence Act (LkSG) in German Language.

Download